The prognostic role of tumor infiltrating T-lymphocytes in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis

por de Ruiter, Emma J., Ooft, Marc L., Devriese, Lot A., Willems, Stefan M.
Publicado 2017

The prognostic role of NK cells and their ligands in squamous cell carcinoma of the head and neck: a systematic review and meta-analysis

por Bisheshar, Sangeeta K., De Ruiter, Emma J., Devriese, Lot A., Willems, Stefan M.
Publicado 2020

Patterns, Predictors, and Prognostic Value of Skeletal Muscle Mass Loss in Patients with Locally Advanced Head and Neck Cancer Undergoing Cisplatin-Based Chemoradiotherapy

por Chargi, Najiba, Wegner, Inge, Markazi, Navid, Smid, Ernst, de Jong, Pim, Devriese, Lot, de Bree, Remco
Publicado 2021

The Predictive Value of Low Skeletal Muscle Mass Assessed on Cross-Sectional Imaging for Anti-Cancer Drug Toxicity: A Systematic Review and Meta-Analysis

por Huiskamp, Laura F. J., Chargi, Najiba, Devriese, Lot A., May, Anne M., Huitema, Alwin D. R., de Bree, Remco
Publicado 2020

The association of pretreatment low skeletal muscle mass with chemotherapy dose‐limiting toxicity in patients with head and neck cancer undergoing primary chemoradiotherapy with hi...

por Bril, Sandra I., Al‐Mamgani, Abrahim, Chargi, Najiba, Remeijer, Peter, Devriese, Lot A., de Boer, Jan Paul, de Bree, Remco
Publicado 2021

First experiences with (177)Lu-PSMA-617 therapy for recurrent or metastatic salivary gland cancer

por Klein Nulent, Thomas J. W., van Es, Robert J. J., Willems, Stefan M., Braat, Arthur. J. A. T., Devriese, Lot A., de Bree, Remco, de Keizer, Bart
Publicado 2021

Diagnostic and Treatment-Related Challenges in Sinonasal Teratocarcinosarcoma: A Report of Three Cases

por Scheurleer, W. F. Julius, Braunius, Weibel W., Tijink, Bernard M., Janssen, Luuk M., Pameijer, Frank A., Breimer, Gerben E., Smid, Ernst J., de Bree, Remco, Devriese, Lot A., Rijken, Johannes A.
Publicado 2023

Low dose cisplatin weekly versus high dose cisplatin every three weeks in primary chemoradiotherapy in head and neck cancer patients with low skeletal muscle mass: The CISLOW-study...

por Schaeffers, Anouk W. M. A., Devriese, Lot A., van Gils, Carla H., Dankbaar, Jan Willem, Voortman, Jens, de Boer, Jan Paul, Slingerland, Marije, Hendriks, Mathijs P., Smid, Ernst J., Frederix, Geert W. J., de Bree, Remco
Publicado 2023

ModraDoc006, an oral docetaxel formulation in combination with ritonavir (ModraDoc006/r), in metastatic castration‐resistant prostate cancer patients: A phase Ib study

por Vermunt, Marit A. C., Robbrecht, Debbie G. J., Devriese, Lot A., Janssen, Julie M., Thijssen, Bas, Keessen, Marianne, van Eijk, Maarten, Kessels, Rob, Eskens, Ferry A. L. M., Beijnen, Jos H., Mehra, Niven, Bergman, Andries M.
Publicado 2021

Author Correction: Accurate detection of circulating tumor DNA using nanopore consensus sequencing

por Marcozzi, Alessio, Jager, Myrthe, Elferink, Martin, Straver, Roy, van Ginkel, Joost H., Peltenburg, Boris, Chen, Li-Ting, Renkens, Ivo, van Kuik, Joyce, Terhaard, Chris, de Bree, Remco, Devriese, Lot A., Willems, Stefan M., Kloosterman, Wigard P., de Ridder, Jeroen
Publicado 2023

Accurate detection of circulating tumor DNA using nanopore consensus sequencing

por Marcozzi, Alessio, Jager, Myrthe, Elferink, Martin, Straver, Roy, van Ginkel, Joost H., Peltenburg, Boris, Chen, Li-Ting, Renkens, Ivo, van Kuik, Joyce, Terhaard, Chris, de Bree, Remco, Devriese, Lot A., Willems, Stefan M., Kloosterman, Wigard P., de Ridder, Jeroen
Publicado 2021

Eight years of experience with vismodegib for advanced and multiple basal cell carcinoma patients in the Netherlands: a retrospective cohort study

por Verkouteren, Babette J. A., Wakkee, Marlies, Reyners, An K. L., Nelemans, Patty, Aarts, Maureen J. B., Rácz, Emőke, Terra, Jorrit B., Devriese, Lot A., Alers, Robert-Jan, Kapiteijn, Ellen, van Doorn, Remco, Bekkenk, Marcel W., Reinders, Marie G.H.C., Mosterd, Klara
Publicado 2021

Eftozanermin alfa (ABBV-621) monotherapy in patients with previously treated solid tumors: findings of a phase 1, first-in-human study

por LoRusso, Patricia, Ratain, Mark J., Doi, Toshihiko, Rasco, Drew W., de Jonge, Maja J. A., Moreno, Victor, Carneiro, Benedito A., Devriese, Lot A., Petrich, Adam, Modi, Dimple, Morgan-Lappe, Susan, Nuthalapati, Silpa, Motwani, Monica, Dunbar, Martin, Glasgow, Jaimee, Medeiros, Bruno C., Calvo, Emiliano
Publicado 2022

Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial

por Ferris, Robert L, Spanos, William C, Leidner, Rom, Gonçalves, Anthony, Martens, Uwe M, Kyi, Chrisann, Sharfman, William, Chung, Christine H, Devriese, Lot A, Gauthier, Helene, Chiosea, Simon I, Vujanovic, Lazar, Taube, Janis M, Stein, Julie E, Li, Jun, Li, Bin, Chen, Tian, Barrows, Adam, Topalian, Suzanne L
Publicado 2021

The association between skeletal muscle measures and chemotherapy‐induced toxicity in non‐small cell lung cancer patients

por de Jong, Corine, Chargi, Najiba, Herder, Gerarda J.M., van Haarlem, Simone W.A., van der Meer, Femke, van Lindert, Anne S.R., ten Heuvel, Alexandra, Brouwer, Jan, de Jong, Pim A., Devriese, Lot A., Huitema, Alwin D.R., Egberts, Toine C.G., de Bree, Remco, Deneer, Vera H.M.
Publicado 2022

Phase 1 study of the pan-HER inhibitor dacomitinib plus the MEK1/2 inhibitor PD-0325901 in patients with KRAS-mutation-positive colorectal, non-small-cell lung and pancreatic cance...

por van Geel, Robin M. J. M., van Brummelen, Emilie M. J., Eskens, Ferry A. L. M., Huijberts, Sanne C. F. A., de Vos, Filip Y. F. L., Lolkema, Martijn P. J. K., Devriese, Lot A., Opdam, Frans L., Marchetti, Serena, Steeghs, Neeltje, Monkhorst, Kim, Thijssen, Bas, Rosing, Hilde, Huitema, Alwin D. R., Beijnen, Jos H., Bernards, René, Schellens, Jan H. M.
Publicado 2020